Global Molecular Diagnostics Market Report: 2013 Edition- Koncept Analytics

7/28/2019 Global Molecular Diagnostics Market Report: 2013 Edition- Koncept Analytics

http://slidepdf.com/reader/full/global-molecular-diagnostics-market-report-2013-edition-koncept-analytics 1/9



Executive Summary

Human race has been persistently involved in a never ending pursuit for discovery and innovation in every field with a special inclinationtowards medical sciences. The perseverant efforts have triggered swift evolution in the realm of diagnostic tools and techniques. In-vitrodiagnostic (IVD) tests are deployed for examining specimens including blood and tissues extracted from human body chiefly in order todetect the presence of concerning physiological/pathological state, or concerning congenital abnormality. Under the IVD market falls the„Molecular Diagnostics‟ sector which involves performing analysis at the molecular level, and thereby measurement of DNA, RNA, proteinsor metabolites to detect genotypes, mutations or biochemical changes, or to test for specific states of health or disease. Such diagnosticmethods are capable of detecting viruses, bacteria, and parasites at a fast pace with greater sensitivity and specificity.

The molecular diagnostics procedures for infectious diseases including HPV, CT/NG; and the deadly gene linked cancer represent thelargest market category in terms of revenue generation. Since the realm of cancer detection and screening procedures is undergoing amajor change, the Oncology segment of the market is poised to undergo noteworthy expansion in the near future thereby driving themolecular diagnostics market on the holistic basis.

As of now, the global molecular diagnostics market is characterized by growth in large value mergers and acquisitions, personalizedtreatment in the field of Oncology and reimbursement trend. While the global molecular diagnostics marketplace remains marred bychallenges like rising price pressures and growing regulatory hurdles; the underlying growth drivers including the ever increasing demandfor better healthcare solutions, coupled with ageing world population, reimbursement, increasing insurance density, growing demand for genetic testing and rising new incidences of cancer, are taking the molecular diagnostics market to new heights.

The report analyzes the global molecular diagnostics market on a global scale and its various segments and also provides detailedinformation regarding the key umbrella markets including the diagnostics and IVD industry. It further discusses the various industry trends,growth drivers and challenges faced by the respective industry. In addition to the market contention prevalent in the global molecular diagnostics market, major industry players including Roche Holdings, Abbott Laboratories, Hologic and Novartis AG are profiled herein.

By combining SPSS Inc.‟s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of theindustry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base todetermine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

View Report Details

http://www.konceptanalytics.com/reportDetail.aspx?reportID=476




In-vitro diagnostic (IVD) tests are medical tests performed in order to diagnose diseases throughchemical assays in a controlled environment outside a living organism. ..

The global diagnostics market was valued at US$........billion in2005, which increased up to US$........ billion in the year end 2011at the compound annual growth rate of ………..% during the citedperiod.

As of 2011, the global IVD market showed an increase of

approximately ………% rising from US$........... billion in 2010 toUS$........... billion in 2011. The same registered a CAGR of approximately ………….% for period spanning 2006 to 2011

As of 2012, the key segments of the global IVD market includedimmunochemistry which constituted ………..% of the market,while self monitoring blood glucose accounted for …………%share. On the other hand, point of care diagnostics constituted…………% share followed by molecular diagnostics with ……..%share.

2006 2007 2008 2009 2010 2011

U S $ B i

l l i o n

Global Diagnostics Market (2005-2012E)

Global IVD Market (2006-2011)

2005

2006

2007

2008

2009

2010

2011

2012E

US$ Billion

Immunochemistry Self Monitoring Blood Glucose

Point of Care Diagnostics Molecular Diagnostics

Tissue Diagnostics Hematology

Microbiology Hemostasis

IVD Market Share by Major Segments (2012)



Molecular diagnostics (MDx) involve performing analysis at the molecular level, and thereby measurementof DNA, RNA, proteins or metabolites to detect genotypes, mutations or biochemical changes, or to test

for specific states of health or disease. ..

The global molecular diagnostics market was worth US$...... billion in2005, which has recorded a CAGR of ……….% reaching US$..... billionin 2012. The market recorded a Y-O-Y growth of ……..% in 2012.

Infectious disease testing accounted for ……% of the molecular diagnostic market, while oncology market constituted nearly ….% andgenetics & prenatal claimed the remaining ………% of the respectivemarket.

In 2007, the market for genetic testing was valued at US$...... billion andit registered a CAGR of ………% to reach US$......... billion in 2011.Currently, genetic testing is being acknowledged as a highly attractivesegment in the molecular diagnostics market. Many factors like direct toconsumer genetic testing, and growing awareness regarding the positiveaspects of genetic testing are driving the market.

Global Genetic Testing Market (2007-2011)Molecular Diagnostics Market Share by Segment

)

Global Molecular Diagnostics Market (2005-2012)

Infectious disease Genetic & Prenatal Oncology

2005 2006 2007 2008 2009 2010 2011 2012

U S $ B i l l i o n

2007 2008 2009 2010 2011

U S $ B

i l l i o n



In molecular diagnostics industry, the growth is driven primarily by population demographics andadvancements made in medical knowledge and technology

The global IVD market is highly consolidated with the 5 key players controlling more than 60% of the global operations. In 2012, thekey players including Roche, Siemens, Abbott, Johnson and Johnson, and Danaher constituted …….% of the global IVD market

Abbott and Novartis held …….% share each in the molecular diagnostic market, which puts them in a No. 2 position, butconsiderably behind market leader Roche which accounts for ……….% share.

Taking into account the numerous factors and growth drivers affecting the growth of global molecular diagnostics market, for theyear 2013, the market opportunity of the same is anticipated to be US$..........billion, estimated to increase by ……% as compared tothe US$.........billion that existed in 2012. The global molecular diagnostics market is likely to grow from US$.............. billion in 2012to US$...... billion in 2015, at a CAGR of ………..%. The strong future projection for the growth in the molecular diagnostics market ismainly on the back of rising incidences of cancer. The market is expected to be driven by a number of factors, such as risingawareness among the people with respect to better healthcare options, and development of various advanced treatment solutions

Note: Market attractiveness is inverse of penetration. Low penetration means high attractiveness and vice-versa

2010

2011

2012

2013F

2014F

2015F

US$ Billion

Roche Abbott Novartis

Hologic Qiagen Becton Dickinson

Cepheid Siemens Others

Global Molecular Diagnostics Market Forecast (2010-2015F)Global Molecular Diagnostics Market Share by Company (2012)



Table of Contents1. Diagnostics: An Overview

1.1 In Vitro Diagnostics1.2 Molecular Diagnostics

2. Diagnostics Market Structure

2.1 In Vitro Diagnostics (IVD) Market-Market Value-Market Segments

2.2 Global Molecular Diagnostics Market-Market Value-Market Segments

2.2.1 Molecular Diagnostics - Segment Analysis

a) HPV-Market Value-Penetration Rate

b) CT/NG-Market Value

2.2.2 Global Genetic Testing Market-Market Value

3. Market Dynamics3.1 Industry Trends and Developments

3.1.1 Molecular Diagnostics in Oncology: Focus onPersonalized Treatment3.1.2 Growing M&A Activity in the Molecular Diagnostics Landscape3.1.3 Reimbursement3.1.4 Penetrating Point of Care Diagnostics3.1.5 Emerging Korean Molecular DiagnosticsBusiness

List of Charts & Tables

List of Charts

IVD Market – Segments by TechnologyMolecular Diagnostcs – Traditional ProcessMain Purposes of Molecular DiagnosticsGlobal Diagnostics Market (2005-2012E)Global IVD Market (2006-2011)

IVD Market Share by Major Segments (2012)Global Molecular Diagnostics Market (2005-2012)Molecular Diagnostics Market Share by SegmentInfectious Disease Market SegmentationHPV Testing Market Penetration Rates in the US (2010-2013E)Global Genetic Testing Market (2007-2011)Current Standards of Care in Various Therapeutic Areas (2011)Number of IVD M&A‟s per Year (2009-2012)Number of M&A Deals According to Primary IVD Target Company Focus(2009-2012)

Number of IVD Partnership Deals by Deal TypeNumber of Cancer Cases Worldwide (2007-2011)World Population with Diabetes, Age Group 20-79 years (2006-2012)Global Ageing Population (2005-2013F)Global GDP (2001-2011)World GDP per Capita (2005-2011)Global Insurance Density (2004-2011)Global Vitamin D Market (2007-2011)Vitamin D Tests Penetration by Region (2011E)Number of Genetic Tests and Laboratories Available Worldwide (1993-2011)Worldwide Number of Diseases with Availability of Genetic Testing (2005-

2011)Global IVD Market Share by Company (2012)Global Molecular Diagnostics Market Share by Company (2012)Global CT/GC Market Share by Leading Companies (2011)Hologic‟s Revenue Share by Business Segment (2012)Hologic‟s Revenues and Net Income (2008-2012) Abbott Laboratories Revenue – Share by Segments (2012) Abbott Laboratories Revenue (2008-2012)



3.2 Growth Drivers

3.2.1 Increasing Prevalence of Cancer 3.2.2 Rising Demand for Better Healthcare Options3.2.3 Diabetic Population3.2.4 Growing Ageing Population (+60 Years)3.2.5 Ameliorating Economic Conditions3.2.6 Increasing Insurance Density3.2.7 Low Penetration of Vitamin D Tests

3.2.8 Growth in Genetic Testing Procedures

3.3 Challenges

3.3.1 Stringent Regulations3.3.2 Mounting Price Pressure

4. Competitive Landscape-Competitive Overview-Market Share

5. Company Profiles

5.1 Hologic, Inc.

5.1.1 Business Overview5.1.2 Financial Overview5.1.3 Business Strategies-Focus on Research & Development-Expansion via Strategic Acquisitions

5.2 Abbott Laboratories

5.2.1 Business Overview5.2.2 Financial Highlights5.2.3 Business Strategies-Mergers and Acquisitions-Expansion in Emerging Markets

5.3 Roche Holdings AG

5.3.1 Business Overview5.3.2 Financial Overview

List of Charts

Roche‟s Revenues by Business Segments (2012)

Roche‟s Revenues and Net Income (2008-2012)Novartis‟ Revenue Share by Business Segments (2012)

Novartis‟ Revenues and Net Income (2008-2012)Global Molecular Diagnostics Market Forecast (2010-2015F)

List of Tables

Global HPV Market Model (2011-2015E)CT/NG Market Model (2011-2015E)Main M&A Deals in the Molecular Diagnostics Sector (2009-2012)Patients Worldwide Waiting for Better Treatment Options (2011)IVD Market Key Players-by SegmentsDependent & Independent Variables (2007-2012)Correlation MatrixModel Summary – Coefficient of DeterminationRegression Coefficients Output



5.3.3 Business Strategies-Focus on Innovative Diagnostics-Expertise in Molecular Biology

5.4 Novartis AG

5.4.1 Business Overview5.4.2 Financial Overview5.4.3 Business Strategies-Strong Product Pipeline-Leadership in Innovation

6. Market Outlook

6.1 Market Forecast6.2 Forecast Methodology

6.2.1 Dependent and Independent Variables

6.2.2 Correlation Analysis6.2.3 Regression Analysis



Koncept Analytics

CS-36, Second Floor, Ansal Plaza

Vaishali, Ghaziabad,

U.P. – 201010

T. +91-120-4130959

C: +91-9811715635

[email protected]

Contact Us:

www.konceptanalytics.com

Vikas Gupta

BD Manager

These are abridged and sanitized sample pages from the comprehensive report on the “Global Molecular Diagnostics Market”.To know more about this report or for any customized research requirement, please contact the following:

View Report Details




Documents

Global Molecular Diagnostics Market Report: 2013 Edition- Koncept Analytics